{"nct_id":"NCT00853372","title":"AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With Sunitinib","status":"COMPLETED","status_verified_date":"2020-05","start_date":"2009-05-28","start_date_type":"ACTUAL","primary_completion_date":"2011-08-08","primary_completion_date_type":"ACTUAL","completion_date":"2019-06-25","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}